A detailed history of Summit Trail Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 4,066 shares of SNY stock, worth $196,306. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,066
Holding current value
$196,306
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$48.54 - $58.53 $197,363 - $237,982
4,066 New
4,066 $234,000
Q3 2018

Nov 14, 2018

SELL
$40.0 - $44.84 $31,320 - $35,109
-783 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$37.63 - $41.22 $348,115 - $381,326
-9,251 Reduced 92.2%
783 $31,000
Q1 2018

May 22, 2018

SELL
$38.98 - $45.76 $9.06 Million - $10.6 Million
-232,350 Reduced 95.86%
10,034 $242,000
Q1 2018

May 21, 2018

BUY
$38.98 - $45.76 $9.13 Million - $10.7 Million
234,309 Added 2901.66%
242,384 $242,000
Q4 2017

Feb 14, 2018

BUY
$42.86 - $50.61 $346,094 - $408,675
8,075
8,075 $356,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.